emcure pharmaceuticals ipo: growth plans, existing profit & more | all you need to know
Published 1 month ago • 5.4K plays • Length 20:11Download video MP4
Download video MP3
Similar videos
-
4:06
emcure pharma ipo: all you need to know before investing
-
1:33
emcure pharmaceuticals ipo: satish mehta expands on biotech brands and upcoming products
-
5:08
emcure pharma ipo: namita thappar on tie up with sanofi & in-house products for cardiac segment
-
3:45
emcure pharma ipo open for subscription today, all you need to know! | investors & valuation |et now
-
12:08
ola electric, akums drugs & ceigall india: should you subscribe to these ipos or not? i ipo news
-
12:35
firstcry ceo supam maheshwari, when will the company turn profitable? | ipo kyc | cnbc tv18
-
9:27
harish krishnan's take on market mood & liquidity | long vs short term sectors & stock ideas! | news
-
10:37
firstcry ceo supam maheshwari on ipo, india growth outlook | ipo kyc | cnbc tv18
-
3:00
emcure pharma ipo launches today; everything you need to know about the pharma company
-
5:44
emcure pharma ipo launch: what to expect? market expert sneha poddar analysis the ipo debut
-
0:59
emcure pharma lists at 31% premium over ipo price, management to focus on emerging markets
-
19:33
everything you need to know about emcure pharmaceuticals ipo
-
11:29
emcure pharmaceuticals ipo | apply or avoid?
-
6:57
akums drugs and pharmaceuticals ipo - apply or avoid? akums drugs and pharmaceuticals ipo analysis
-
7:44
emcure pharma ipo to open next week, rationale behind the fundraise & utilization plans | et now
-
19:05
akums drugs ipo: key details, issue price, outlook post listing & more
-
1:31
strong debut for emcure pharma: lists at 31% premium
-
0:51
emcure pharma ipo good or bad to invest?
-
0:53
emcure pharma ipo listing: shares debut at nearly 32% premium over ipo price | n18s | cnbc tv18
-
1:00
ipo alert | emcure pharma & bansal wire | ipo listing | n18s | cnbc tv18
-
2:19
emcure pharma makes a stellar debut, lists at 31% premium to issue price | cnbc tv18
-
8:00
emcure pharma ipo - opportunity or high valuation? | emcure pharma analysis |